Dr. Derek A. Haas
Medical Director
Conceive Fertility Center
7515 Greenville Ave Ste 1030
Dallas , TX 75231
United States
drhaas@cfcivf.comFEI 3014721365Issued Jan 27, 2026Center for Biologics Evaluation and Research (CBER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3014721365.
Violations10
Issue DateJan 27, 2026
Product TypeBiologics
StatusOpen
Letter Details
Firm
Conceive Fertility Center
Location
Dr. Derek A. Haas
Medical Director
Conceive Fertility Center
7515 Greenville Ave Ste 1030
Dallas , TX 75231
United States
drhaas@cfcivf.com
FEI Number
3014721365
Country
United States
Issue Date
January 27, 2026
Issuing Office
Center for Biologics Evaluation and Research (CBER)
Product Type
Biologics
Status
Open
Summary
Conceive Fertility Center, a fertility clinic handling human reproductive cells and tissues (biologics), failed to adequately screen egg and sperm donors for communicable disease risks as required under 21 CFR 1271.75(a)(1). During a June 2025 FDA inspection, the agency identified that the facility's Donor Medical History Interview Form—used to evaluate approximately 61 anonymous egg donors, 40 directed egg donors, and 79 directed sperm donors between January 2022 and June 2025—was missing critical screening questions, timeframes, and deferral periods necessary to assess donors' risk factors for HIV, hepatitis B, hepatitis C, and other relevant communicable diseases. The violations represented significant deviations from the federal regulations governing human cells, tissues, and cellular products under Section 361 of the Public Health Service Act.
Conceive Fertility Center FDA Warning Letter, January 27, 2026